Northern Trust’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.07M Buy
280,226
+4,107
+1% +$78.3K ﹤0.01% 2451
2025
Q4
$6M Sell
276,119
-10,982
-4% -$315K ﹤0.01% 2367
2025
Q3
$9.36M Buy
287,101
+31,720
+12% +$1.17M ﹤0.01% 2155
2025
Q2
$9.06M Sell
255,381
-31,240
-11% -$1.01M ﹤0.01% 2131
2025
Q1
$9.73M Buy
286,621
+1,943
+0.7% +$69.7K ﹤0.01% 2051
2024
Q4
$9.26M Buy
284,678
+200,786
+239% +$8.32M ﹤0.01% 2175
2024
Q3
$4.09M Sell
83,892
-20
-0% -$1.06K ﹤0.01% 2593
2024
Q2
$3.72M Sell
83,912
-4
-0% -$185 ﹤0.01% 2559
2024
Q1
$4.71M Buy
83,916
+1,440
+2% +$86.8K ﹤0.01% 2499
2023
Q4
$4.96M Sell
82,476
-59,421
-42% -$3.77M ﹤0.01% 2524
2023
Q3
$9.53M Sell
141,897
-2,261
-2% -$157K ﹤0.01% 2040
2023
Q2
$9.95M Sell
144,158
-31,759
-18% -$2.08M ﹤0.01% 2068
2023
Q1
$8.48M Buy
175,917
+66,224
+60% +$3.24M ﹤0.01% 2131
2022
Q4
$5.48M Buy
109,693
+789
+0.7% +$38.2K ﹤0.01% 2427
2022
Q3
$4.44M Buy
108,904
+5,549
+5% +$260K ﹤0.01% 2560
2022
Q2
$5.68M Buy
103,355
+8,812
+9% +$372K ﹤0.01% 2423
2022
Q1
$3.44M Buy
+94,543
New +$3.74M ﹤0.01% 2801

Other funds holding LEGN

Northern Trust's LEGN Position: Q1 2026 in Review

Northern Trust increased its Legend Biotech (LEGN) stake by 1.5% in Q1 2026, buying an estimated $78.3K and bringing the position to 280,226 shares worth $5.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2451.

Northern Trust first reported a position in LEGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $9.95M in Q2 2023. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Northern Trust held 280,226 shares of Legend Biotech worth $5.07M as of Q1 2026.
  • Northern Trust bought 4,107 Legend Biotech shares in Q1 2026, an estimated $78.3K.
  • Legend Biotech made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2451 holding.
  • Northern Trust first reported a position in Legend Biotech in Q1 2022 and has held it in 17 quarters since.
  • Northern Trust's Legend Biotech position peaked at $9.95M in Q2 2023.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.